Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia

Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia

US Patent 8268837 · Granted Sep 18, 2012

Estimated economic value: $20,360,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of skin disorders2025
Heated lubricant pump2025
Organic compositions to treat HSF1-related diseases2024
Treatment of skin lesions2024
Treatment of neurological disorders2024
Combination comprising at least one spliceosome modulator and at least one inhib2022
Treatment of skin disorders2022
Organic compositions to treat HSF1-related diseases2021
Piston pump and seal ring2021
Treatment of skin lesions2021
Organic compositions to treat HSF1-related diseases2019
Organic compositions to treat beta-catenin-related diseases2018